Pediatric anesthesia & critical care

Population pharmacokinetic-pharmacodynamic analysis and dose optimisation of ciprofol in paediatric anaesthesia

Br J AnaesthPublished Population pharmacokinetic-pharmacodynamic modelling study

Authors' conclusion

A ciprofol induction dose of 0.6 mg kg-1 followed by a weight-stratified maintenance infusion of 1.0-1.4 mg kg-1 h-1 is recommended for paediatric anaesthesia.

Study context

Population
Paediatric patients (0.08–15 yr; weight 4.2–71.0 kg) undergoing cardiac or thoracic surgery
Participants
88 patients
Comparison
Ciprofol induction 0.6 vs 0.9 mg kg-1
Outcome
PopPK/PD model and dose recommendations
Methodological detailsopportunistic blood sampling, effect compartment model, simulation-based dosing
  • Opportunistic blood sampling
  • Effect compartment model
  • Simulation-based dosing

Main finding

As reported in the abstract

Recommended induction dose

0.6 mg kg-1

Recommended maintenance (target BIS 40-60), weight 0-5 kg

1.4 mg kg-1 h-1

Recommended maintenance, weight 5-30 kg

1.2 mg kg-1 h-1

Recommended maintenance, weight >30 kg

1.0 mg kg-1 h-1

Original publication

Population pharmacokinetic-pharmacodynamic analysis and dose optimisation of ciprofol in paediatric anaesthesia. Br J Anaesth. Published 2 July 2026. doi:10.1016/j.bja.2026.04.077

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.